Marek Pruszynski (Marek Pruszyński)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 10

Top Venues

Materials (Basel, Switzerland)

Nanomaterials (Basel, Switzerland)

Molecular cancer therapeutics

Molecules (Basel, Switzerland)

University of Warsaw

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Warsaw Sep 03 2018

Poland

Ph.D.; D.Sc.

Institute of Nuclear Chemistry and Technology Dec 02 2002

Poland

Ph.D.; D.Sc.; Professor of INCT :: Radiochemistry and Nuclear Chemistry

Publications

Magdalena Rodak, Yana Dekempeneer, Maria Wojewódzka, Vicky Caveliers, Peter Covens, Brian W Miller, Matthijs B Sevenois, Frank Bruchertseifer, Alfred Morgenstern, Tony Lahoutte, Matthias D'Huyvetter, Marek Pruszynski
Preclinical Evaluation of 225Ac-Labeled Single-Domain Antibody for the Treatment of HER2pos Cancer. Molecular cancer therapeutics 21 (12) (2022)
Monika Kalinowska, Kamila Gryko, Ewelina Gołębiewska, Grzegorz Świderski, Hanna Lewandowska, Marek Pruszynski, Małgorzata Zawadzka, Maciej Kozłowski, Justyna Sienkiewicz-Gromiuk, Włodzimierz Lewandowski
Fe(III) and Cu(II) Complexes of Chlorogenic Acid: Spectroscopic, Thermal, Anti-/Pro-Oxidant, and Cytotoxic Studies. Materials (Basel, Switzerland) 15 (19) (2022)
Monika Kalinowska, Ewelina Gołębiewska, Liliana Mazur, Hanna Lewandowska, Marek Pruszynski, Grzegorz Świderski, Marta Wyrwas, Natalia Pawluczuk, Włodzimierz Lewandowski
Crystal Structure, Spectroscopic Characterization, Antioxidant and Cytotoxic Activity of New Mg(II) and Mn(II)/Na(I) Complexes of Isoferulic Acid. Materials (Basel, Switzerland) 14 (12) (2021)
Janik Puttemans, Benoit Stijlemans, Marleen Keyaerts, Sam Vander Meeren, Wim Renmans, Karel Fostier, Pieterjan Debie, Heleen Hanssens, Magdalena Rodak, Marek Pruszynski, Kim De Veirman, Karin Vanderkerken, Tony Lahoutte, Alfred Morgenstern, Frank Bruchertseifer, Nick Devoogdt, Matthias D'Huyvetter
The Road to Personalized Myeloma Medicine: Patient-specific Single-domain Antibodies for Anti-idiotypic Radionuclide Therapy. Molecular cancer therapeutics (2021)
Weronika Gawęda, Marek Pruszynski, Edyta Cędrowska, Magdalena Rodak, Agnieszka Majkowska-Pilip, Damian Gawel, Frank Bruchertseifer, Alfred Morgenstern, Aleksander Bilewicz
Trastuzumab Modified Barium Ferrite Magnetic Nanoparticles Labeled with Radium-223: A New Potential Radiobioconjugate for Alpha Radioimmunotherapy. Nanomaterials (Basel, Switzerland) 10 (10) (2020)
Malwina Czerwińska, Giulio Fracasso, Marek Pruszynski, Aleksander Bilewicz, Marcin K Kruszewski, Agnieszka Majkowska-Pilip, Anna Lankoff
Design and Evaluation of 223Ra-Labeled and Anti-PSMA Targeted NaA Nanozeolites for Prostate Cancer Therapy-Part I. Materials (Basel, Switzerland) 13 (17) (2020)
Edyta Cędrowska, Marek Pruszynski, Weronika Gawęda, Michał Żuk, Paweł Krysiński, Frank Bruchertseifer, Alfred Morgenstern, Maria-Argyro Karageorgou, Penelope Bouziotis, Aleksander Bilewicz
Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with 225Ac as a Perspective Tool for Combined α-Radioimmunotherapy and Magnetic Hyperthermia of HER2-Positive Breast Cancer. Molecules (Basel, Switzerland) 25 (5) (2020)
Łucja Dziawer, Agnieszka Majkowska-Pilip, Damian Gawel, Charlotte Gimpel, Marek Pruszynski, Jerzy Jastrzębski, Bogdan Wąs, Aleksander Bilewicz
Trastuzumab-Modified Gold Nanoparticles Labeled with 211At as a Prospective Tool for Local Treatment of HER2-Positive Breast Cancer. Nanomaterials (Basel, Switzerland) 9 (4) (2019)
Marek Pruszynski, Choong Mo Kang, Eftychia Koumarianou, Ganesan Vaidyanathan, Michael R Zalutsky
d-Amino Acid Peptide Residualizing Agents for Protein Radioiodination: Effect of Aspartate for Glutamate Substitution. Molecules (Basel, Switzerland) 23 (5) (2018)
Marek Pruszynski, Matthias D'Huyvetter, Frank Bruchertseifer, Alfred Morgenstern, Tony Lahoutte
Evaluation of an Anti-HER2 Nanobody Labeled with 225Ac for Targeted α-Particle Therapy of Cancer. Molecular pharmaceutics 15 (4) (2018)

Marek Pruszynski.css-eqlu8i{font-size:small;padding-left:4px;} (Marek Pruszyński)

Publication Activity (10 Years)

Top Topics

Top Venues

Marek Pruszynski (Marek Pruszyński)